Literature DB >> 22832510

Vitamin and mineral status in patients with inflammatory bowel disease.

Razan H Alkhouri1, Humaira Hashmi, Robert D Baker, Daniel Gelfond, Susan S Baker.   

Abstract

OBJECTIVES: Patients with inflammatory bowel disease (IBD) are at risk for vitamin and mineral deficiencies because of long-term inflammation in the gut mucosa and decreased oral intake. The aim of the study is to investigate the prevalence of vitamin and zinc deficiencies in patients with newly diagnosed IBD compared with a control group.
METHODS: This is a retrospective chart review of all of the patients diagnosed as having IBD from 2006 to 2010, ages 1 to 18 years. Patients who had fat- and water-soluble vitamins (A, E, D 25-OH, folate, and B(12)) and zinc levels obtained at time of diagnosis were included in the study. A total of 61 patients with IBD and 61 age- and sex-matched controls were included.
RESULTS: None of the 61 patients with IBD had folate or vitamin B12 deficiency. Vitamin D deficiency was found in 62% of the patients, vitamin A deficiency in 16%, vitamin E deficiency in 5%, and zinc deficiency in 40%. The control group had vitamin D and E and zinc deficiency in 75%, 8%, and 19% patients, respectively.
CONCLUSIONS: We conclude that vitamin B12 and folate deficiencies are rare in children with newly diagnosed IBD in the United States and we question whether routine monitoring is warranted. Vitamin A and zinc deficiency are common in patients with newly diagnosed IBD and levels should be assessed at the time of diagnosis so that enteral repletion can commence. Vitamin D deficiency is common in all of the children in the Buffalo, NY, area, and routine screening for this deficiency is warranted.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22832510     DOI: 10.1097/MPG.0b013e31826a105d

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  50 in total

Review 1.  Management of Anemia in Patients with Inflammatory Bowel Disease (IBD).

Authors:  Dhruvan Patel; Chinmay Trivedi; Nabeel Khan
Journal:  Curr Treat Options Gastroenterol       Date:  2018-03

Review 2.  Epithelial transport in inflammatory bowel diseases.

Authors:  Fayez K Ghishan; Pawel R Kiela
Journal:  Inflamm Bowel Dis       Date:  2014-06       Impact factor: 5.325

3.  Vitamin D Deficiency and Supplementation in Patients with IBD.

Authors:  Helen Pappa
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-02

Review 4.  Diet as a Therapeutic Option for Adult Inflammatory Bowel Disease.

Authors:  Samir Kakodkar; Ece A Mutlu
Journal:  Gastroenterol Clin North Am       Date:  2017-12       Impact factor: 3.806

Review 5.  Vitamins and Minerals in Inflammatory Bowel Disease.

Authors:  Fayez K Ghishan; Pawel R Kiela
Journal:  Gastroenterol Clin North Am       Date:  2017-10-03       Impact factor: 3.806

Review 6.  Review article: vitamin D and inflammatory bowel diseases.

Authors:  V P Mouli; A N Ananthakrishnan
Journal:  Aliment Pharmacol Ther       Date:  2013-11-17       Impact factor: 8.171

Review 7.  Zinc and Selenium in Inflammatory Bowel Disease: Trace Elements with Key Roles?

Authors:  Mostafa Vaghari-Tabari; Davoud Jafari-Gharabaghlou; Fatemeh Sadeghsoltani; Parisa Hassanpour; Durdi Qujeq; Nadereh Rashtchizadeh; Amir Ghorbanihaghjo
Journal:  Biol Trace Elem Res       Date:  2020-10-23       Impact factor: 3.738

Review 8.  Microbiome-Epigenome Interactions and the Environmental Origins of Inflammatory Bowel Diseases.

Authors:  Tatiana Y Fofanova; Joseph F Petrosino; Richard Kellermayer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-02       Impact factor: 2.839

9.  Zinc Deficiency is Associated with Poor Clinical Outcomes in Patients with Inflammatory Bowel Disease.

Authors:  Shivi Siva; David T Rubin; George Gulotta; Kristin Wroblewski; Joel Pekow
Journal:  Inflamm Bowel Dis       Date:  2017-01       Impact factor: 5.325

Review 10.  Advances in nutritional therapy in inflammatory bowel diseases: Review.

Authors:  Andrzej Wędrychowicz; Andrzej Zając; Przemysław Tomasik
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.